202 related articles for article (PubMed ID: 20961309)
21. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation.
Karpanen T; Wirzenius M; Mäkinen T; Veikkola T; Haisma HJ; Achen MG; Stacker SA; Pytowski B; Ylä-Herttuala S; Alitalo K
Am J Pathol; 2006 Aug; 169(2):708-18. PubMed ID: 16877368
[TBL] [Abstract][Full Text] [Related]
22. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
23. 3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model.
Hwang-Bo J; Bae MG; Park JH; Chung IS
BMC Cancer; 2018 Jul; 18(1):714. PubMed ID: 29976150
[TBL] [Abstract][Full Text] [Related]
24. A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma.
Ebos JM; Bocci G; Man S; Thorpe PE; Hicklin DJ; Zhou D; Jia X; Kerbel RS
Mol Cancer Res; 2004 Jun; 2(6):315-26. PubMed ID: 15235107
[TBL] [Abstract][Full Text] [Related]
25. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
Chen HM; Tsai CH; Hung WC
Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
[TBL] [Abstract][Full Text] [Related]
26. Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands.
Chung ES; Chauhan SK; Jin Y; Nakao S; Hafezi-Moghadam A; van Rooijen N; Zhang Q; Chen L; Dana R
Am J Pathol; 2009 Nov; 175(5):1984-92. PubMed ID: 19808642
[TBL] [Abstract][Full Text] [Related]
27. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.
Kubo H; Cao R; Brakenhielm E; Mäkinen T; Cao Y; Alitalo K
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8868-73. PubMed ID: 12070340
[TBL] [Abstract][Full Text] [Related]
28. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins.
Hong YK; Lange-Asschenfeldt B; Velasco P; Hirakawa S; Kunstfeld R; Brown LF; Bohlen P; Senger DR; Detmar M
FASEB J; 2004 Jul; 18(10):1111-3. PubMed ID: 15132990
[TBL] [Abstract][Full Text] [Related]
29. Lymphangiogenesis by blind-ended vessel sprouting is concurrent with hemangiogenesis by vascular splitting.
Parsons-Wingerter P; McKay TL; Leontiev D; Vickerman MB; Condrich TK; Dicorleto PE
Anat Rec A Discov Mol Cell Evol Biol; 2006 Mar; 288(3):233-47. PubMed ID: 16489601
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic transformation of intimal and adventitial lymphatics in atherosclerosis: a regulatory role for soluble VEGF receptor 2.
Taher M; Nakao S; Zandi S; Melhorn MI; Hayes KC; Hafezi-Moghadam A
FASEB J; 2016 Jul; 30(7):2490-9. PubMed ID: 27006449
[TBL] [Abstract][Full Text] [Related]
31. Crosstalk between angiogenesis and lymphangiogenesis in tumor progression.
Scavelli C; Vacca A; Di Pietro G; Dammacco F; Ribatti D
Leukemia; 2004 Jun; 18(6):1054-8. PubMed ID: 15057248
[TBL] [Abstract][Full Text] [Related]
32. VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing.
Saito T; Takeda N; Amiya E; Nakao T; Abe H; Semba H; Soma K; Koyama K; Hosoya Y; Imai Y; Isagawa T; Watanabe M; Manabe I; Komuro I; Nagai R; Maemura K
FEBS Lett; 2013 Jul; 587(14):2179-85. PubMed ID: 23711375
[TBL] [Abstract][Full Text] [Related]
33. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
[TBL] [Abstract][Full Text] [Related]
34. Detection and quantification of complexed and free soluble human vascular endothelial growth factor receptor-1 (sVEGFR-1) by ELISA.
Hornig C; Behn T; Bartsch W; Yayon A; Weich HA
J Immunol Methods; 1999 Jun; 226(1-2):169-77. PubMed ID: 10410982
[TBL] [Abstract][Full Text] [Related]
35. VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation.
Dohlman TH; Omoto M; Hua J; Stevenson W; Lee SM; Chauhan SK; Dana R
Transplantation; 2015 Apr; 99(4):678-86. PubMed ID: 25606789
[TBL] [Abstract][Full Text] [Related]
36. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
[TBL] [Abstract][Full Text] [Related]
37. Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?
Goyal S; Chauhan SK; El Annan J; Nallasamy N; Zhang Q; Dana R
Arch Ophthalmol; 2010 Jul; 128(7):819-24. PubMed ID: 20625040
[TBL] [Abstract][Full Text] [Related]
38. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis.
Maertens L; Erpicum C; Detry B; Blacher S; Lenoir B; Carnet O; Péqueux C; Cataldo D; Lecomte J; Paupert J; Noel A
PLoS One; 2014; 9(9):e106976. PubMed ID: 25222747
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis.
Schomber T; Zumsteg A; Strittmatter K; Crnic I; Antoniadis H; Littlewood-Evans A; Wood J; Christofori G
Mol Cancer Ther; 2009 Jan; 8(1):55-63. PubMed ID: 19139113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
